Home » Topics » BioWorld Science

BioWorld Science
RSS

Oryzon announces preclinical collaboration with Seaver Autism Center at Mount Sinai

April 7, 2021

Forevertek Biotechnology and ProMab Biotechnologies divulge MAbs against SLAM family member 7

April 7, 2021

Japanese investigators identify P2X4 receptor antagonists

April 7, 2021

Cadila Healthcare presents new NLRP3 inflammasome inhibitors

April 7, 2021

Roche divulges new TLR antagonists

April 7, 2021

U.S. researchers patent protein kinase inhibitors

April 7, 2021

Unnatural Products describes MDM2/4 bispecific inhibitor UNP-1797

April 7, 2021

Myeloid cells differ in primary and recurrent glioblastoma

April 7, 2021

Antibodies could make things worse in neurodegeneration

April 7, 2021

First patient dosed in a phase II study of ensovibep for the treatment of COVID-19

April 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...